ArticleFrontiers in oncology2026
A postoperative recurrence prediction model for intrahepatic cholangiocarcinoma based on multi-omics analysis of adjacent-to-tumor tissues.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The patients with intrahepatic cholangiocarcinoma (iCCA) are highly susceptible to recurrence after radical resection, while predicting recurrence remains challenging. Adjacent-to-tumor tissues (ATTs), as the main microenvironment for postoperative recurrence, exhibited superior predictive value for recurrence compared with tumor tissues. However, the postoperative recurrence prediction model based on iCCA ATTs characteristics has not been studied. This study aims to construct recurrence prediction model based on iCCA ATTs and discover possible beneficial postoperative treatment options. Methods: Consensus clustering was employed to classify the proteome of 116 iCCA ATTs. Multivariate Cox regression was used to construct recurrence prediction model. Tissue microarray containing 88 iCCA ATTs (another independent cohort) and immunohistochemistry were used for validating the expression of target proteins. Results: We classified iCCA ATTs into two subtypes (S1 and S2) based on 116 iCCA patients' proteomic data, where S1 exhibited higher recurrence rates and immune scores than those of S2. We constructed a multivariate Cox regression model based on four molecules (ENO3, HSPA13, POSTN, PTBP3). The expression of POSTN was an independent prognostic factor for recurrence of iCCA. The high-risk group for recurrence exhibited a poorer response to immunotherapy but was more sensitive to certain chemotherapy and targeted therapies. Conclusions: We obtained novel molecular subtyping and constructed a postoperative recurrence prediction model based on iCCA ATTs, offering novel perspectives for tumorigenesis and providing some references for postoperative treatment options.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.